SI
Sonavex, Inc.
SEC filingBiotechnology · Baltimore, MD
Amount raised$3.1Msold at filing
Total offering$15M$11.9M still open
Investors in the raise5count reported to the SEC
FiledJul 28, 2026first sale Jul 13, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Alex YevzlinExecutive Officer
David NarrowExecutive Officer, Director
Robert HallenbeckDirector
Devin O'Brien-CoonDirector
William NilandDirector
Michael J. Hennessy, Jr.Director
Evan PritchardDirector
Executive officers, directors and promoters as listed on the Form D.